<> Neuland Laboratories Share Price Today: Live Neuland Laboratories Share Price NSE/BSE | 5paisa
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • News
  • FAQs

    • Neuland Laboratories Share PriceNeuland Laboratories

    Small Cap 994
    ₹1420.15
    21.4 (1.53%)
    As on 05 February, 2023 | 19:27 BSE: 524558 NSE: NEULANDLAB
    Announcements Dividends

    Neuland Laboratories Performance

    Day Range

    • Low
    • High

    52 Week Range

    • Low
    • High
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Neuland Laboratories

    Start SIP

    Neuland Laboratories Share Price

    • Over 1 Month -17.15%
    • Over 3 Month -3.51%
    • Over 6 Month 21.66%
    • Over 1 Year 9.46%

    Neuland Laboratories Key Statistics

    P/E Ratio 22
    PEG Ratio 1.6
    Market Cap Cr 1,822
    Price to Book Ratio 2.2
    EPS 50.6
    Dividend 0.4
    Relative Strength Index 33.64
    Money Flow Index 13.16
    MACD Signal -52.47
    Average True Range 77.43

    Neuland Laboratories Investment Rating

    • Master Rating:

    • Neuland Laboratories has an operating revenue of Rs. 1,007.22 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 9% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Neuland Laboratories Financials
    IndicatorSep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 294221256
    Operating Expenses Qtr Cr 225193217
    Operating Profit Qtr Cr 692839
    Depreciation Qtr Cr 131312
    Interest Qtr Cr 333
    Tax Qtr Cr 1532
    Net Profit Qtr Cr 381022

    Neuland Laboratories Technicals

    EMA & SMA

    Current Price
    ₹1420.15
    21.4 (1.53%)
    • Bullish Moving Average
    • ___
    • 1
    • Bearish Moving Average
    • ___
    • 15
    • 20 Day
    • 1539.75
    • 50 Day
    • 1593.09
    • 100 Day
    • 1550.2
    • 200 Day
    • 1481.17
    • 20 Day
    • 1575.13
    • 50 Day
    • 1646.33
    • 100 Day
    • 1574
    • 200 Day
    • 1373.88

    Neuland Laboratories Resistance and Support

    PIVOT
    ₹1388.62
    Resistance
    First Resistance 1459.14
    Second Resistance 1519.52
    Third Resistance 1590.04
    RSI 33.64
    MFI 13.16
    MACD Single Line -52.47
    MACD -69.8
    Support
    First Resistance 1328.24
    Second Resistance 1257.72
    Third Resistance 1197.34

    Neuland Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 33,771 1,454,179 43.06
    Week 35,110 1,465,149 41.73
    1 Month 28,842 1,424,781 49.4
    6 Month 63,245 2,203,443 34.84

    Neuland Laboratories Result Highlights

    Neuland Laboratories Synopsis

    NSE-Medical-Diversified

    Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 951.08 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2022. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.
    Market Cap 1,835
    Sales 1,007
    Shares in Float 0.82
    No of funds 56
    Yield 0.35
    Book Value 2.21
    U/D Vol ratio 0.9
    LTDebt / Equity 12
    Alpha 0.13
    Beta 0.74

    Neuland Laboratories

    Owner NameDec-22Sep-22Jun-22Mar-22
    Promoters 36.14%36.22%36.22%
    Mutual Funds 0.79%0.79%0.79%
    Foreign Portfolio Investors 17.7%17.68%17.37%
    Financial Institutions/ Banks
    Individual Investors 30.09%31.02%33.25%
    Others 15.28%14.29%12.37%

    Neuland Laboratories Management

    Name Designation
    Dr. Davuluri Rama Mohan Rao Executive Chairman
    Mr. Davuluri Sucheth Rao Vice Chairman & CEO
    Mr. Davuluri Saharsh Rao Vice Chairman & Mng.Director
    Dr. Christopher M Cimarusti Non Executive Director
    Mr. Humayun Dhanrajgir Ind. Non-Executive Director
    Mrs. Bharati Rao Ind. Non-Executive Director
    Dr. Nirmala Murthy Ind. Non-Executive Director
    Mr. Parampally Vasudeva Maiya Ind. Non-Executive Director
    Mr. Homi Rustum Khusrokhan Ind. Non-Executive Director

    Neuland Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Neuland Laboratories Corporate Action

    Date Purpose Remarks
    2023-02-13 Quarterly Results
    2022-11-10 Quarterly Results
    2022-08-03 Quarterly Results
    2022-05-10 Audited Results & Final Dividend
    2022-02-01 Quarterly Results
    Date Purpose Remarks
    2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend

    Neuland Laboratories MF Shareholding

    Name Amount(cr)
    Quant Small Cap Fund Growth 2870
    Motilal Oswal S&P BSE Healthcare ETF 6

    Neuland Laboratories FAQs

    What is Share Price of Neuland Laboratories ?

    Neuland Laboratories share price is ₹1420 As on 05 February, 2023 | 19:13

    What is the Market Cap of Neuland Laboratories ?

    The Market Cap of Neuland Laboratories is ₹1822 Cr As on 05 February, 2023 | 19:13

    What is the P/E ratio of Neuland Laboratories ?

    The P/E ratio of Neuland Laboratories is 22 As on 05 February, 2023 | 19:13

    What is the PB ratio of Neuland Laboratories ?

    The PB ratio of Neuland Laboratories is 2.2 As on 05 February, 2023 | 19:13

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from NSDL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2022, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.